TMEM87A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.543000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.572000E-01
Normal-vs-Stage2
3.076200E-01
Normal-vs-Stage3
6.495000E-01
Normal-vs-Stage4
1.664440E-01
Stage1-vs-Stage2
5.402000E-01
Stage1-vs-Stage3
9.526400E-01
Stage1-vs-Stage4
3.546400E-01
Stage2-vs-Stage3
6.722000E-01
Stage2-vs-Stage4
6.657000E-01
Stage3-vs-Stage4
5.432000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.653200E-01
Normal-vs-AfricanAmerican
3.098200E-01
Normal-vs-Asian
4.811200E-01
Caucasian-vs-AfricanAmerican
8.201600E-01
Caucasian-vs-Asian
8.552200E-01
AfricanAmerican-vs-Asian
9.372600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.056600E-01
Normal-vs-Female
3.100000E-01
Male-vs-Female
4.342400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.011400E-01
Normal-vs-Age(41-60Yrs)
1.942630E-01
Normal-vs-Age(61-80Yrs)
4.741400E-01
Normal-vs-Age(81-100Yrs)
3.081400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.423400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.698400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.226400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.364000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.236100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.278200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.637800E-01
Normal-vs-Daily Drinker
3.891000E-01
Normal-vs-Weekly Drinker
6.215800E-01
Normal-vs-Occasional Drinker
3.189000E-01
Normal-vs-Social Drinker
4.230200E-01
Non Drinker-vs-Daily Drinker
5.136600E-01
Non Drinker-vs-Weekly Drinker
5.470000E-01
Non Drinker-vs-Occasional Drinker
2.810200E-01
Non Drinker-vs-Social Drinker
9.988600E-01
Daily Drinker-vs-Weekly Drinker
3.011800E-01
Daily Drinker-vs-Occasional Drinker
6.863200E-01
Daily Drinker-vs-Social Drinker
5.819400E-01
Weekly Drinker-vs-Occasional Drinker
1.768040E-01
Weekly Drinker-vs-Social Drinker
5.551400E-01
Occasional Drinker-vs-Social Drinker
3.604400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.143610E-01
Normal-vs-Grade 2
3.456900E-03
Normal-vs-Grade 3
1.364280E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.785600E-04
Grade 1-vs-Grade 3
2.393200E-04
Grade 1-vs-Grade 4
1.143610E-01
Grade 2-vs-Grade 3
1.455230E-01
Grade 2-vs-Grade 4
3.456900E-03
Grade 3-vs-Grade 4
1.364280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.704000E-01
Normal-vs-NonDiabetic
3.216400E-01
Diabetic-vs-NonDiabetic
2.050800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.140800E-01
Normal-vs-NoPancreatitis
3.709600E-01
Pancreatitis-vs-NoPancreatitis
3.931000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.540600E-01
Normal-vs-N1
2.893000E-01
N0-vs-N1
1.644000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.967800E-02
Normal-vs-TP53-NonMutant
5.216600E-01
TP53-Mutant-vs-TP53-NonMutant
1.25939999995328E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
